Aegerion Pharmaceuticals, Inc. (AEGR) Posts Q1 Loss of 55c/Share

Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) reported Q1 EPS of ($0.55), $0.01 worse than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Aegerion Pharmaceuticals, Inc. (AEGR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Baird removes Fresh Pick on Huntington and comments on banks
• Bonk, Inc. posts $5.5M revenue in H1 2026, reports $7.88M net loss